@article{bbd7babc8a394768959ad8f50a5ec4eb,
title = "Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China",
keywords = "COVID-19, blood pressure control, cardiac injury, hypertension, renin-angiotensin-aldosterone system suppressors, Hospital Mortality, Angiotensin Receptor Antagonists, Humans, Hypertension/epidemiology, SARS-CoV-2, Angiotensin-Converting Enzyme Inhibitors, Retrospective Studies, China/epidemiology",
author = "\{China Medical Treatment Expert Group for COVID-19\} and Tao Wang and Ruidi Tang and Honglian Ruan and Ruchong Chen and Zili Zhang and Ling Sang and Xi Su and Shuting Yi and Zhengyi Ni and Yu Hu and Lei Liu and Hong Shan and Chunliang Lei and Yixiang Peng and Chunli Liu and Jing Li and Cheng Hong and Nuofu Zhang and Nanshan Zhong and Shiyue Li",
note = "{\textcopyright} 2021 John Wiley \& Sons Ltd.",
year = "2021",
month = aug,
doi = "10.1111/crj.13382",
language = "English",
volume = "15",
pages = "915--924",
journal = "Clinical Respiratory Journal",
issn = "1752-6981",
number = "8",
}